US Patent Issued to UNIVERSITY OF IOWA RESEARCH FOUNDATION on July 14 for "Respiratory syncytial virus (RSV) polyanhydride nanoparticle vaccine" (Iowa Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,410, issued on July 14, was assigned to UNIVERSITY OF IOWA RESEARCH FOUNDATION (Iowa City, Iowa).

"Respiratory syncytial virus (RSV) polyanhydride nanoparticle vaccine" was invented by Steven M. Varga (Coralville, Iowa) and Kevin L. Legge (North Liberty, Iowa).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compositions and methods for vaccinating susceptible individuals against infection by respiratory syncytial virus (RSV). The disclosed compositions include vaccine compositions comprising an effective amount of respiratory syncytial virus (RSV) F protein in a pre-fusion stabilized form and/or M protein incorporated into biodegradable ...